This inventor holds 1 USPTO granted patent. Top assignee: Ablynx N.v.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joâo Vieira and Patent Innovation in T-Cell Immunotherapy
Introduction
Joâo Vieira is an inventor associated with Didcot, Great Britain, and Ablynx N.V. His recorded patent concerns engineered polypeptides designed to support T-cell recruitment in immunotherapy.
Latest Patents
Vieira is associated with 1 patent: “T Cell Recruiting Polypeptides Capable of Binding CD123 and TCR Alpha/Beta.” The invention describes polypeptides capable of binding CD123 and the alpha/beta T-cell receptor, an approach intended to bring T cells into contact with target cells.
Career Highlights
The available information links Vieira’s inventive work to Ablynx N.V. and the development of a patent in the field of T-cell-directed therapeutics. The supplied details do not specify his role, employment dates, or other career milestones.
Collaborations
The patent’s association with Ablynx N.V. indicates a connection between Vieira’s invention and the company’s research and development activities. No additional collaborators are identified in the provided information.
Conclusion
Joâo Vieira’s recorded patent reflects work on T-cell-recruiting polypeptides that bind CD123 and the alpha/beta T-cell receptor, connecting his inventive activity with Ablynx N.V.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile